Background: Carrier-mediated influx of cytosolic deoxynucleotides is a major source of precursors for mitochondrial DNA synthesis.
Results: dRIM2 is required to maintain normal deoxynucleotide pools in Drosophila mitochondria, and its knock-out is lethal at the larval stage.
Conclusion: dRIM2 is a deoxynucleotide carrier and is essential to maintain mitochondrial function.
Significance: Our data provide the first animal model of RIM2 deficiency.
Keywords: Drosophila, Mitochondria, Mitochondrial DNA, Mitochondrial Transport, Nucleotide
Abstract
The CG18317 gene (drim2) is the Drosophila melanogaster homolog of the Saccharomyces cerevisiae Rim2 gene, which encodes a pyrimidine (deoxy)nucleotide carrier. Here, we tested if the drim2 gene also encodes for a deoxynucleotide transporter in the fruit fly. The protein was localized to mitochondria. Drosophila S2R+ cells, silenced for drim2 expression, contained markedly reduced pools of both purine and pyrimidine dNTPs in mitochondria, whereas cytosolic pools were unaffected. In vivo drim2 homozygous knock-out was lethal at the larval stage, preceded by the following: (i) impaired locomotor behavior; (ii) decreased rates of oxygen consumption, and (iii) depletion of mtDNA. We conclude that the Drosophila mitochondrial carrier dRIM2 transports all DNA precursors and is essential to maintain mitochondrial function.
Introduction
Deoxy- and ribonucleoside triphosphates (dNTPs and rNTPs) are essential for the replication and transcription of the mitochondrial genome. An appropriate supply of these precursors is thus necessary for the maintenance of functional mitochondria throughout the life of cells and organisms (1, 2). The main site of deoxy- and ribonucleotide synthesis is the cytoplasm where they are produced by two de novo pathways interconnected through the ribonucleoside diphosphates, which are both the immediate precursors of rNTPs and the substrates for ribonucleotide reductase, the key enzyme in the de novo synthesis of dNTPs (3). De novo synthesis of thymidylate, the first committed step of thymidine deoxynucleotide de novo synthesis, occurs in the nucleus and in the mitochondrial matrix (4, 5). In most but not all organisms, NTPs and dNTPs are also synthesized by salvage of (deoxy)nucleosides by dedicated nucleoside and nucleotide kinases. Mammals contain two parallel deoxynucleoside salvage pathways, located in the cytosol and in mitochondria, respectively. The rate-limiting enzymes are two cytosolic and two mitochondrial (mt)3 deoxynucleoside kinases whose combined substrate specificities permit the salvage of all deoxynucleosides in each of the two subcellular compartments (6). Ribonucleotide salvage consists primarily in the recycling of ribonucleosides and free purine bases and occurs in the cytoplasm.
The nuclear envelope is freely permeable to nucleotides, and the precursors made in the cytoplasm are therefore easily available for nuclear DNA replication and transcription. The mt inner membrane is instead impermeable to nucleotides, and cytosolic nucleotides need membrane carriers to reach the mt matrix where mtDNA transactions take place. At present, only a few mt nucleotide carriers are known (7). In yeast, they include the three isoforms of the ATP/ADP exchanger, a GTP/GDP carrier (Ggc1p) (8) and a (deoxy)nucleotide carrier (Rim2p) (9). Two human genes, SLC25A33 and SLC25A36 (7, 10), were suggested to code for nucleotide carriers on the basis of their homology to the Saccharomyces cerevisiae RIM2. The prediction has been confirmed only in the case of SLC25A33 (11, 12).
The product of SLC25A33 is a protein 33% identical to Rim2p. It has been named PNC1 (11) to highlight its function as a pyrimidine nucleotide carrier, demonstrated by transport studies with the recombinant protein reconstituted in liposomes (11) and later by isotope flow experiments in intact cells (12). The transport properties of yeast Rim2p and human PNC1 are very similar. When reconstituted into liposomes, both proteins exchange all pyrimidine ribo- and deoxyribonucleotides and show some activity with guanine nucleotides but not with adenine nucleotides. Thus, they appear to be responsible for the import of most nucleic acid precursors into mitochondria. The characterization of Rim2p activity led to the proposal that the carrier imports nucleoside triphosphates in exchange with monophosphates (9).
Rim2p deletion had been found to cause total loss of mtDNA in yeast long before the transport activity of the protein had been identified biochemically (13). So far, there are no data on the in vivo effects of PNC1 loss of function in humans or mice. The existing information comes from experiments of PNC1 silencing by siRNA in cultured human cells. Knockdown (KD) of PNC1 led to depletion of mtDNA and reduced transcription of mt genes and impairment of oxidative phosphorylation (11, 14). In situ analysis of nucleotide flow in cells with down-regulation of PNC1 revealed a slower mitochondrial uptake of uridine triphosphate and a slower release of thymidine nucleotides to the cytoplasm (12). The same study investigated also the function of the SLC25A36 gene product. Down-regulation of the protein, which is 60% identical to PNC1, had no effect on mitochondrial pools. Therefore, the activity of SLC25A36 remains unknown (12).
The genome of Drosophila melanogaster contains only one gene with significant similarity to yeast Rim2 and the two human genes. This gene, denominated CG183173 and indicated here as drim2, maps on chromosome 2 (position 22B1), spans 7,503 bp, and produces three different transcripts, all containing the typical features of mitochondrial carriers (15). There is currently no information concerning the functions of drim2. On account of its homology to Rim2p and PNC1, it may be involved in the mitochondrial transport of nucleotides. We considered that it could be a useful model to investigate how the deletion of a nucleotide carrier affects mitochondrial function in a multicellular animal.
We first silenced drim2 expression in the Drosophila S2R+ cell line (16) and found depletion of all mitochondrial dNTP pools, suggesting that the protein is involved in the transport of all four DNA precursors. We then produced drim2 knock-out (KO) flies and found that the homozygous loss of drim2 is lethal, blocking larval development at the third instar. We analyzed different phenotypic aspects of the drim2−/− larvae detecting profound alterations of mitochondrial structure and function and impairment of larval locomotion that could be related to depletion of mtDNA. Our data suggest that drim2 codes for a nucleotide transporter essential for the maintenance of functional mitochondria in Drosophila.
EXPERIMENTAL PROCEDURES
Cell Cultures
The Drosophila S2R+ cell line was derived from a primary culture of late stage (20–24 h old) D. melanogaster embryos (16). It was obtained from Drosophila Genomics Resource Center. S2R+ cells grow at 25 °C without CO2 in Schneider's medium (Invitrogen) with 10% heat-inactivated fetal bovine serum (FBS) (Sigma) as a loose semi-adherent monolayer, showing a doubling time of about 48 h.
dsRNA Production and RNAi Procedures
dsRNAi synthesis was performed employing the T7 Megascript kit (Invitrogen) (17, 18). The oligonucleotide primers used to synthesize dsRNA starting from cDNA were drim2_T7 forward (F) and reverse (R) (primer sequences are reported in Table 1). These primers give two complementary 700-bp RNA products that anneal as temperature decreases, forming a final 700-bp dsRNA. About 2 × 106 cells suspended in 1 ml of serum-free medium were mixed with 2 μg/ml dsRNA, plated in a 24-well plate, and incubated at room temperature (RT) for 1 h. Subsequently, 1 volume of complete medium (2×) was added, and cells were grown in the presence of dsRNA for 2 days at 25 °C.
TABLE 1.
Primer name | Sequence 5′–3′ |
---|---|
drim2_T7 F | taatacgactcactatagggagatgtatgcgttttgccaaagttaaa |
drim2_T7 R | taatacgactcactatagggagaatggtacaccctctcgatgcactg |
drim2KOe01575F | atttcgcctcacagctttg |
drim2KOe01575R | gatgacaaagtgcaccatcg |
drim2KOe00041F | ctcttcgattctgggcattc |
drim2KOe00041R | tactattcctttcactcgcacttattg |
drim2 F | tcggttacggatcgaacaa |
drim2R | tcggttacggatcgaacaa |
CoxI F | tgctcctgatatagcattcccacga |
CoxI R | tccaccatgagcaattccagcgg |
16S F | aaaaagattgcgacctcgat |
16S R | aaaccaacctggcttacacc |
Rp49 F | tcggttacggatcgaacaa |
Rp49 R | gacaatctccttgcgcttct |
Rpl32 F | aggcccaagatcgtgaagaa |
Rpl32 R | tgtgcaccaggaacttcttgaa |
dNTP Pool Extraction and Analysis
At the end of the treatment with dsRNA, about 10 × 106 S2R+ cells were centrifuged in 15-ml tubes for 10 min at 400 × g, and the pellet was washed twice with ice-cold PBS. The cells were then resuspended in 200 μl of extraction buffer (0.21 m mannitol, 0.07 m sucrose, 0.2 m EGTA, 10 mm Tris-HCl, pH 7.5, 0.5% BSA), and a suspension of glass beads (0.1 mm diameter) corresponding to about ½ the volume of the cellular pellet was added. The cell/bead suspension was introduced in a Bullet Blender Storm homogenizer (Next Advance) and shaken for 2 min at speed 8, and then 400 μl of extraction buffer were added, and the glass beads were removed by a short centrifugation. Mitochondrial and cytosolic nucleotide pools were isolated from the whole cell homogenate by differential centrifugation and methanol extraction as described (19). All manipulations took place in a cold room. The pellet remaining after mitochondrial pool extraction was dissolved in 1 ml of 0.3 m NaOH. The A260 nm of the NaOH fraction was used to normalize the number of cells from which the pools of the different samples were extracted (20). The sizes of the dNTP pools were determined with a DNA polymerase-based assay (21) with the modifications reported previously (22). Two different aliquots of each pool extract were analyzed, and pool sizes were expressed as pmol of dNTPs/million cells, with cell numbers calculated as indicated above.
Immunolocalization of dRIM2
HA-tagged drim2 cDNA was cloned in a pACT vector under the control of actin 5c promoter (23). 500,000 cells were seeded on round coverslips and grown for 16 h, and then they were transfected with 20 μl of CellFectin II reagent and 2.5 μg of vector and incubated for 8 h. The medium was removed and replaced with complete Schneider medium (containing 10% heat-inactivated FBS). 48 h from transfection, cells were washed once with 1× PBS and incubated with 100 nm MitoTracker Red CMXROS and 1 μg/ml cyclosporin H in Schneider's Medium for 20 min (23). Then the cells were washed in 1× PBS and fixed in 4% paraformaldehyde for 20 min. After a second wash in PBS, cells were permeabilized for 5 min with 50 mm NH4Cl in PBS + 0.1% Triton X-100, then blocked for 1 h in 3% goat serum in PBS, washed again, and incubated with 1:100 monoclonal mouse α-HA antibody (Sigma) at 4 °C overnight. Cells were washed again with PBS and then incubated with 1:500 FITC-conjugated α-mouse IgG (Sigma) with 2% goat serum for 45 min. After a final wash in PBS, the slides were mounted with Vectashield mounting medium. Images were taken with a Leica SP5 confocal microscope at ×63 magnification.
Fly Stocks and Breeding Conditions
Flies were raised on standard cornmeal medium and were maintained at 23 °C, 70% relative humidity, on a 12-h light/dark cycle. The UAS fly strains (transformant IDs 44203 and 44202) used to perform post-transcriptional silencing were from the Vienna Drosophila RNAi Center. Other D. melanogaster strains were obtained from the Bloomington Stock Center.
Egg-to-Adult Viability
For each of the transgenic lines, around 300 fertilized eggs were collected on standard yeast/glucose/agar medium in a Petri dish (60 × 15 mm). The fertilized eggs were incubated at 23 °C, and for each experimental condition, the number of individuals reaching the third instar larva, pupa, or adult, and the relative percentages were calculated (24).
Genomic DNA Extraction
Single individuals (flies or larvae) were homogenized in separate vials in 50 μl of extraction buffer containing 10 mm Tris-HCl, pH 8.2, 1 mm EDTA, and 25 mm NaCl. Proteinase K was added to a final concentration of 200 μg/ml, and the homogenate was incubated for 45 min at 37 °C followed by heat inactivation of the enzyme at 95 °C for 5 min. Genomic DNA used to quantify the mtDNA copy number was extracted from 10 larvae using the phenol/chloroform DNA extraction protocol.
Primers
All oligonucleotides used in this work are reported in the Table 1. They were designed using the on-line tool Primer-BLAST (25).
Generation of Knock-out Strain
We obtained from Exelixis Drosophila Stock Center available stocks bearing PiggyBac insertions (PBac(RB) CG18317e01575 and PBac(RB) CG18317e00041) at the boundaries of the drim2 locus. To obtain the gene deletion, we exploited the specific recombination between the FRT element within the PBac elements catalyzed by FLP recombinase (26, 27). The obtained KO lines were checked for the presence of the deletion. To this purpose, the following couples of primers were used upstream deletion (drim2KOe01575 F and R), giving a product size of 150 nucleotides, and downstream deletion (drim2KOe00041 F and R), giving a product size of 240 nucleotides.
RNA Isolation and qRT-PCR Experiments
Total RNA was extracted from ∼10 larvae or 2 × 106 cells using TRIzol (Invitrogen) and further purified by precipitation with 8 m LiCl. RNA samples were checked for integrity by capillary electrophoresis (RNA 6000Nano LabChip, Agilent Technologies). For each sample, 1 μg of RNA was used for first strand cDNA synthesis, employing 10 mm deoxynucleotides, 10 μm oligo(dT), and SuperScript II (Invitrogen). qRT-PCRs were performed in triplicate in a 7500 Real Time PCR system (Invitrogen) using SYBR Green chemistry (Promega). The 2−ΔΔCt (relative quantification) method implemented in the 7500 Real Time PCR system software was used to calculate the relative expression ratio (28). The drim2 oligonucleotide primer used was drim2 F and R. Specific primers were designed for CoxI (CoxI F and R).The 16S primers used were 16S F and R (29). Rp49 was used as endogenous control, and the oligonucleotides employed were Rp49 F and R.
Body Wall Preparations
A small portion of the tip was cut from third instar larvae; internal organs were removed by gently squeezing from end to end, and the preparation was turned inside-out by rolling the cuticula along a holding tweezer.
Mitochondrial Pattern in Muscle Fibers
Body wall preparations of larvae were stained with 500 nm MitoTracker Red CMXRos (Invitrogen) for 45 min. Tissues were then washed in 1× PBS and fixed in 4% paraformaldehyde for 20 min. After a brief wash, they were mounted in 80% glycerol. Scans of muscle six were taken with a Leica SP5 Confocal Microscope at ×63 magnification.
Measurements of Oxygen Consumption
Oxygen measurements were made using the XF24 Extracellular flux analyzer (Seahorse Bioscience). Measurements were performed both in whole tissues of Drosophila larvae (body wall preparations) and in S2R+ Drosophila cells, using different Seahorse technologies. The instrument was maintained at a temperature of 25 °C. In the case of tissues, each dissected larvae was placed into a well of an islet capture 24-well microplate. Islet capture screens were used to keep the larvae in place. Basal oxygen consumption rates, reported in the unit of picomoles/min, were measured several times before injecting the first drug to be tested. Chemicals were sequentially added in each well as described in figure legends. Cells were seeded onto XF-24-well plates at 20,000 cells/well and cultured for 48 h. The following day, the culture medium was replaced with serum-free Schneider medium (Invitrogen). Basal oxygen consumption rates were measured three times, and the loaded compounds were then sequentially injected.
Analysis of Larval Locomotor Behavior
The locomotor activity of a single third stage larva inside an arena was recorded for a 120-s period using a video tracking system. The arena consisted in a Petri dish (5 cm in diameter) covered by a thin layer of 1% agar gel. The Petri dish was placed inside a box; the internal walls of the box were painted black, containing a ring of ultrabright white leads to generate a uniform illumination. After closing the box, the movement of the larva inside the arena was video recorded using a Canon digital video camera (10 frames/s). A specific software (AnyMaze) was utilized to track the path covered by the moving animal during the recording time period of 120 s. The software calculated the total length of the path, the average speed, and the maximum speed of the larvae. A total number of 50 larvae were analyzed for each genotype. The tests were performed at the same time of day for all strains.
Electron Microscopy
Third stage larvae were dissected in Ca2+-free hemolymph-like saline-3 (HL3) and transferred into a fixation solution containing 3% glutaraldehyde, 2% paraformaldehyde, 100 mm sucrose, and 2 mm EGTA in 0.1 mm sodium phosphate buffer, pH 7.2. Samples were fixed for 2 h and washed overnight at 4 °C in 0.1 mm phosphate buffer, pH 7.2. Samples were then post-fixed for 2 h with cold 1% OsO4, in 0.1 mm sodium cacodylate buffer, pH 7.2, and rinsed 3–4 times (5 min each) in 0.1 mm sodium phosphate buffer, pH 7.2. Subsequently larvae were dehydrated through an ethanol gradient, followed by a propylene oxide-resin gradient. Finally, the samples were embedded in Epon resin (Sigma) and polymerized at 60 °C for 3 days. The analysis was performed on 60-nm ultrathin sections of larval body wall muscles, stained for 20 min with uranyl acetate, and examined with a Philips CM10 electron microscope (FEI Co.). For statistical analyses, the shortest and the longest diameters of mitochondria were measured using ImageJ software (rsb.info.nih.gov). In addition, we measured the area and the density of mitochondria in the same larvae. In particular, we first measured the area occupied by all cell profiles present on each section for each genotype considered. Over this area, we then measured the total number and the area occupied by mitochondria. The data were collected considering the total area occupied by cell profiles on sections cut at two different levels (about 50 μm apart) of the same block and placed on different grid. The analysis were performed using “Netherlennder” system (30).
Determination of mtDNA Levels
Total DNA from larvae was extracted using phenol/chloroform precipitation. The amount of mtDNA was assessed by the ratio of mtDNA to nuclear DNA (nDNA) copy number determined by quantitative real time amplification of the mitochondrial 16S gene and the nuclear Rpl32 gene. Primers used in this work (16S F and R; Rpl32 F and R) were those reported previously (29). We generated two gene-specific calibration curves with six 10-fold serial dilutions (100–10,000,000 copies) of plasmids containing the cloned target sequences (Invitrogen). Concentration of plasmid stock solutions was assessed with an ND-1000 spectrophotometer (NanoDrop), and the plasmid copy number of dilutions was calculated using Avogadro's number. Reactions were performed in triplicate using SYBR Green chemistry according to the manufacturer's recommendations (GoTaq qPCR Master Mix, Promega) in a 7500 Real Time PCR System instrument (Invitrogen). Data were normalized to the ratio of mtDNA/nDNA copy number in controls (arbitrary set to 100%) (31, 32).
DNA Microarray Design
Probes were designed using the Agilent eArray Custom Microarray Design Service, which applies proprietary prediction algorithms to design 60-mer oligonucleotide probes. Microarrays were synthesized in situ using the Agilent ink-jet technology with 8 × 60 K format. A total of 32,162 probes representing D. melanogaster transcripts were successfully obtained. A custom microarray platform, named “Drosophila 1.0” (eArray Design ID: 035757), showed 30,814 duplicate probes and 1,348 single probes. Each array included default positive (1,011 probes) and negative (308 probes) controls. Probe sequences and other details on the microarray platform can be found in the Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov) under accession number GPL17290.
Microarray Labeling and Hybridization
Gene expression profiling was carried out on drim2−/− and drim2+/− Drosophila larvae using the Drosophila 1.0 custom platform (Agilent Technologies). Total RNA was obtained from the whole body of third instar larvae for each genotype. Four and three biological replicates were analyzed for drim2−/− and drim2+/− samples, respectively, for a total of seven microarray experiments. 800 ng of total RNA was labeled with “Agilent One-color Microarray-based Gene Expression” protocol according to the manufacturer's instructions. The synthesized cDNA was transcribed into cRNA and labeled with Cy3-dCTP. Labeled cRNA was purified with RNeasy mini columns (Qiagen). The quality of each cRNA sample was verified by total yield, and specificity was calculated with NanoDrop ND-1000 spectrophotometer measurements. 1.65 μg of labeled cRNA was used in each reaction, and hybridization was carried out at 65 °C for 17 h in a hybridization oven rotator (Agilent). The arrays were washed using Agilent Gene expression washing buffers and stabilization and drying solution, as suggested by the supplier. Slides were scanned on an Agilent microarray scanner (model G2565CA), and Agilent Feature Extraction software version 10.5.1.1 was used for image analysis. Gene expression data are available in the GEO database with the accession number GSE48012.
Statistical Analysis of Gene Expression Data
Inter-array normalization of expression levels was performed with the quantile method (33) to correct possible experimental distortions. A normalization function was applied to the expression data of all the experiments, and the values of within-array replicate spots were then averaged. Feature Extraction software, which provided spot quality measures, was used to evaluate the quality and reliability of the hybridization. In particular, the flag “glsFound” (set to 1 if the spot had an intensity value significantly different from the local background and to 0 when otherwise) was used to filter out unreliable probes; the flag equal to 0 was to be noted as “not available.” Probes with a high proportion of not available values were removed from the dataset to carry out a more solid, unbiased statistical analysis. Forty percent of the not available was used as the threshold in the filtering process, and a total of 25,350 Drosophila transcripts were obtained. Principal component analysis, cluster analysis, and profile similarity searches were performed with MultiExperiment Viewer version 4.8.1 of the TM4 microarray software suite. The identification of differentially expressed mRNAs was performed with two class Significance Analysis of Microarray programs with default settings (34). The normalized expression values of the biological replicates for each genotype were log2-transformed and mediated. Gene Ontology analysis of differentially expressed genes was performed using the DAVID tool (35).
RESULTS
The Rim2p protein was previously characterized in S. cerevisiae as a mitochondrial pyrimidine nucleotide transporter (9). Yeast Rim2p is a member of the mitochondrial carrier protein family distinguished by some typical features as follows: the amino acid sequences include three repeats, each containing two putative trans-membrane sequences and the signature motif (PX(DE)XX(KR)). Therefore, the main structure fold is a six α-helical bundle (11). To evaluate the degree of conservation of the Rim2p across species, we performed an amino acid alignment of yeast, human, and fruit-fly Rim2p sequences and calculated the levels of homology (Fig. 1). The drim2 gene of D. melanogaster codes for three different transcripts, named A, C, and D. The corresponding protein isoforms showed comparable degrees of similarity to the yeast sequence (≈40%). Interestingly, all Drosophila isoforms are closer to human PNC-1 (52–54% identity) than to yeast Rim2p.
To characterize the subcellular localization of dRIM2, we transfected Drosophila S2R+ cells with a pACT vector expressing HA-tagged dRIM2 cDNA under the control of the actin 5c promoter. MitoTracker staining and immunodetection of HA-dRIM2 with an α-HA monoclonal antibody clearly indicated that dRIM2 localizes to mitochondria (Fig. 2A).
Next, we down-regulated the expression of endogenous drim2 in S2R+ cells and tested the effects on the size of the mitochondrial dNTP pools. In cells incubated for 72 h with dsRNA, real time RT-PCR analysis showed that mRNA was decreased by 80%. If dRIM2 is a carrier for pyrimidine nucleotides, its down-regulation should affect the dTTP and dCTP pools more than the purine deoxynucleotides dATP and dGTP. To test this prediction, we isolated the mitochondrial and cytosolic dNTP pools from control and silenced S2R+ cells by adapting a procedure previously devised for the quantification of mammalian mitochondrial dNTPs (19). No data are available on dNTP pool sizes in Drosophila cells, and we therefore wished to establish the relative abundance of the four dNTPs and the ratios between cytosolic and mitochondrial pools. In mammals, dTTP is generally the largest dNTP pool, and dGTP is the smallest, with dCTP and dATP occupying intermediate positions. Pool sizes in Drosophila are reported in Fig. 2, B and C. As in mammalian cells (22), mitochondrial pool sizes corresponded to about 3–10% those of the cytosolic pools. The dATP pool was the largest in both cytosol and mitochondria, followed by dTTP, dGTP, and dCTP in the cytosol and dTTP, dCTP, and dGTP in mitochondria. In both compartments, the dCTP pool was particularly small and comparable in size to the dGTP pool. Because the sizes of the dNTP pools are strongly influenced by the position of the cell in the cell cycle (36), we took care of comparing the concentrations of dNTPs in cultures of drim2-silenced and control S2R+ cells with similar frequencies of S-phase cells. We observed no difference in the proportion of S-phase cells between silenced and control cultures, with values of about 20–25% depending on the experiment. Therefore, we feel confident that the differences in dNTP pools we measured in the two sets of cultures were not caused by differences in cell cycle distribution. However, although the cytosolic pools were virtually identical in control and silenced cultures (with the exception of the dATP pool that was higher in the latter), all mitochondrial dNTPs were significantly lower in the silenced cells, with levels ranging between 30% (dCTP) and 60% (dATP) of the controls. Thus, down-regulation of drim2 reduced the mitochondrial concentrations of both pyrimidine and purine dNTPs, suggesting that the protein is a general transporter for all four DNA precursors. We cannot extend this conclusion to RNA precursors, as we did not measure the mitochondrial ribonucleotide pools.
Next we attempted to knock down the drim2 gene in vivo by using GAL4/UAS-driven RNAi in living flies (18, 37). Despite high levels of silencing (about 80%) (Fig. 3A), drim2 KD individuals did reach the adult stage and lived longer than the controls (Fig. 3B). No effects on egg to adult viability were observed. These results suggest that even a low residual level of drim2 mRNA is sufficient to maintain the wild-type phenotype.
Thus, we generated a Drosophila drim2 KO using the technique described previously (26) that exploits the specific recombination between FRT sites in the presence of flippase. Heterozygous KO flies (drim2+/−) were balanced with a strain expressing GFP (w; L2, Pin1, CyO-GFP), allowing discrimination between homozygous GFP-negative drim2−/− and heterozygous GFP-positive drim2+/− larvae. Real time-PCR showed that drim2+/− larvae had about 50% drim2 mRNA levels compared with a wild-type control (w1118), whereas drim2−/− flies were null, as expected (Fig. 4A). The drim2−/− third instar larvae were visibly smaller than their heterozygous counterparts (Fig. 4B). Nevertheless, KO larvae did present mouth hooks, the distinctive character of the third larval stage indicating that their smaller size was not due to a developmental delay (Fig. 4C). The KO heterozygous drim2+/− larvae developed into normal adults with no developmental defects. On the contrary, none of drim2−/− larvae reached adulthood. Although drim2−/− individuals survived through larval development, most of them died at the third larval instar, and the survivors failed to progress beyond the pupal stage (Fig. 4D). To further characterize the phenotype, we measured locomotor activities (total distance traveled, overall average speed, and inactivity) with the Any Maze software. Wild-type and drim2+/− larvae behaved similarly, whereas drim2−/− showed marked locomotor defects (Fig. 4, E–G).
Confocal images of body wall preparations stained with MitoTracker Red showed a normal mitochondrial pattern along the z-lines in w1118; however, the drim2−/− individuals showed spatially disorganized mitochondria that failed to line up along the z-lines (Fig. 5A). This abnormal pattern was confirmed by transmission electron microscopy (EM) (Fig. 5B). EM carried out in drim2+/− and drim2−/− larvae (1st panel, Fig. 6A) revealed alterations of mitochondrial number and shape compared with w1118 (Fig. 6A). The drim2+/− mitochondria appeared more elongated and considerably bigger than those of w1118 larvae (Fig. 6A). Morphometric analysis indicated that, on average, the major mitochondrial diameter in drim2+/− larvae was significantly increased, and the minor diameter was reduced relative to w1118 mitochondria (Fig. 6, B and C). In drim2−/− larvae, mitochondria had a rounder shape (Fig. 6A); the averaged major diameter was unchanged relative to the wild type, whereas the minor diameter was longer than that of mitochondria of both w1118 and drim2+/− (Fig. 6, B and C). Accordingly, estimates of the mitochondrial area indicated that drim2+/− organelles were larger than those from w1118 and drim2−/− flies (Fig. 6D). Furthermore, mitochondrial density, i.e. the number of mitochondria per surface unit, was reduced in drim2+/− individuals compared with wild-type controls and significantly higher in drim2−/− larvae (Fig. 6E).
As Rim2 deletion in yeast and PNC1 down-regulation in mammalian cells decreases mtDNA content (13, 14), we measured the mtDNA copy number in KO larvae. Unexpectedly, although mtDNA was almost 40% depleted in drim2+/− larvae, drim2−/− individuals had levels of mtDNA close to wild type (Fig. 7A), possibly a consequence of the higher mitochondrial density (Fig. 6E) (38, 39).
A reduced mtDNA copy number might lead to reduced expression of the mtDNA-encoded subunits of the respiratory chain. We measured the levels of mitochondrial transcripts for Cyclooxygenase-1 (COX1) and RNA (16S) relative to housekeeping gene Rpl32 by real time-PCR (Fig. 7B) (40). Mitochondrial transcription was lower in both drim2−/− and drim2+/− larvae. To establish whether defects in drim2 function also affect mitochondrial respiration, we measured oxygen consumption rates of muscle body wall preparations of Drosophila larvae with the Seahorse technology (41). Controls and drim2+/− larvae maintained a steady respiratory rate that was inhibited by rotenone and antimycin A, demonstrating its mitochondrial origin. On the contrary drim2−/− larvae showed severe impairment of oxygen utilization that was insensitive to respiratory inhibitors (Fig. 8A). The same measurements were performed also in S2R+ cells silenced for drim2. The rate of oxygen consumption was significantly decreased in cells silenced for 96 h, and the cells responded less than the controls to uncoupler (FCCP) and to oligomycin or rotenone plus antimycin A (Fig. 8B). No significant differences of respiratory profile were detected between cells undergoing a mock interfering treatment for almost 48 h and the controls. The basal respiration of the two cultures was similar, both being of mitochondrial origin because they were stimulated by FCCP and inhibited by oligomycin or rotenone plus antimycin A (Fig. 8B).
To define the gene expression pattern specifically associated with drim2 KO, we performed protein-coding microarray analyses (Fig. 9) (Drosophila 1.0 custom platform, Agilent Technologies) on high quality RNA from drim2−/− and drim2+/−. Using Significance Analysis of Microarray two class analysis, we identified 2,964 differentially expressed genes (false discovery rate = 5.10%) of which 1,120 were up-regulated (38%) and 1,844 were down-regulated (62%) in drim2−/− versus drim2+/− samples (supplemental Table S1). A functional annotation web tool (DAVID) was used to identify functional categories occurring in the drim2−/− expression signature more frequently than expected by chance. The Group Enrichment Score was used to rank biological significance of deregulated genes. We observed that Gene Ontology functional categories over-represented in the up-regulated component of the expression signature included oxidative phosphorylation and glycolysis/gluconeogenesis; in contrast, the down-regulated components showed an over-representation of Gene Ontology categories such as purine and pyrimidine metabolism (Fig. 9).
DISCUSSION
Mitochondria contain multiple copies of a small circular DNA coding for essential polypeptide components of the respiratory chain and F-ATP synthase complexes embedded in the inner mitochondrial membrane. Replication and transcription of mtDNA occur during the whole life of the cell, even after it has reached terminal differentiation. Both processes are particularly active during cell proliferation and early development, when mitochondrial biogenesis is induced (42) and thus the request for dNTPs and rNTPs is particularly high. In yeast and mammals, the cytoplasm is the main site for nucleotide production, but some synthesis also occurs in mitochondria and in the nucleus (4, 5). Because of the impermeability of the mitochondrial inner membrane to nucleotides, these are taken up into mitochondria by a partly unknown repertoire of membrane carriers. The nucleotide transporter we have studied here is the Drosophila ortholog of yeast Rim2p and human PNC1, two homologous pyrimidine nucleotide transporters (9, 11, 12).
In yeast, the genetic inactivation of RIM2 causes loss of mtDNA and a petite phenotype (13). In cultured human cells, down-regulation of PNC1 by siRNA can lead to decreased mtDNA copy number (14). Thus, in both yeast and humans the dependence of mitochondria on nucleotides made in the cytosol has been demonstrated.
The study of nucleotide, and especially deoxynucleotide, metabolism has been relatively neglected in Drosophila. Most attention has been dedicated to a distinctive multisubstrate deoxynucleoside kinase responsible for the salvage of all deoxynucleosides (43), as opposed to the four separate deoxynucleoside kinases existing in mammals (6). Given the presence in the genome of the key enzymes for dNTP and rNTP de novo synthesis, we assumed that the general picture defined in mammalian cells also applies to Drosophila and that also in this species mitochondria obtain nucleic acid precursors from extra-mitochondrial sources. Thus, after confirming that dRIM2 is localized to mitochondria (Fig. 2A), we hypothesized that its deletion may impact the mtDNA content and impair mitochondrial transcription, with negative consequences for oxidative phosphorylation and energy-dependent processes.
We studied the effects of dRIM2 ablation on the dNTP pools required for the maintenance of mtDNA. No information was available on the composition of dNTP pools of Drosophila cells, and we first analyzed the total pools of control S2R+ cells. They contained relatively more dTTP and dATP than dCTP and dGTP, a pool composition different from that commonly observed in mammalian cells where dTTP and dCTP frequently are the most abundant dNTPs. When we separated mitochondrial and cytosolic pools we found that, in Drosophila as in human cells, the dNTP pools of mitochondria amount to no more than 10% of the total dNTPs. In drim2-silenced cells, both mitochondrial pyrimidine and purine dNTPs pools were reduced. Although these data only give a static picture of the mitochondrial pools and the actual nucleotide transport was not directly measured, the general decrease of all four dNTPs suggests that dRIM2 acts as a general deoxynucleotide transporter. Cytosolic pools were unaffected, underscoring a specific function of the carrier in the import of nucleotides from the site of their synthesis in the cytoplasm into the mitochondrial matrix where they are consumed for mtDNA synthesis. The possible lack of intramitochondrial dNTP synthesis in Drosophila suggested by the genomic data is supported by the appearance of cell toxicity when silencing was prolonged beyond 3 days. Although the treatment did not completely remove drim2 mRNA, the down-regulation was sufficient to impair cell viability in vitro. This was not the case when we down-regulated the protein in vivo using the GAL4/UAS system to ubiquitously activate drim2-dsRNAi. A 30% residual level of gene activity was sufficient for the flies to develop normally into adults (Fig. 3).
A very different picture appeared after in vivo KO of drim2. Homozygous drim2−/− larvae exhibited a lethal phenotype and died during the third larval stage without reaching adulthood. The homozygous KO produced an overall impairment of larval development associated with reduced dimensions compared with wild-type larvae (Fig. 4, B–D). It is known that most Drosophila mutants for genes involved in mitochondrial and nucleotide metabolism either do not undergo metamorphosis, arresting their development at larval stage or manifest developmental defects. This phenomenon is probably related to the particularly high energetic burden of metamorphosis. Larval lethality is frequently associated with neuromuscular and behavioral defects, functions that in Drosophila are particularly sensitive to OXPHOS-dependent energy drop (44–46). Here, drim2−/− larvae showed severe defects in their locomotor activity (Fig. 4, E–G).
From the morphological point of view, mitochondria of both drim2−/− KO and heterozygous drim2+/− larvae displayed evident anomalies (Fig. 6). EM analysis in drim2−/− larvae revealed a higher mitochondrial density (Fig. 6E), possibly a physiological response compensating for the progressive loss of mitochondrial function. However, expression profiling did not demonstrate activation of mitochondrial biogenesis. Genes such as PGC-1α, NRF-1, NRF-2, and TFAM were not up-regulated in drim2−/− larvae. An alternative explanation for the increased number of mitochondria may be the reduced mitochondrial turnover rather than increased biogenesis.
Interestingly, among the genes involved in nucleotide metabolism that are differentially expressed in homozygous KO larvae, only nucleoside diphosphate kinase was clearly up-regulated, and all others were down-regulated. Because nucleoside diphosphate kinase catalyzes the final step in the synthesis of dNTPs and rNTPs, this result suggests a homeostatic response to reduced availability of nucleoside triphosphates in mitochondria. The down-regulated genes encode both for synthetic and catabolic enzymes and participate in the regulation of different pool components in combination with other enzymes. Changes detected in individual members of a complex enzyme network are difficult to interpret and may reflect general unspecific stress rather than a concerted metabolic adjustment related to the lack of mitochondrial nucleotides.
Despite the severity of the KO phenotype, direct quantitation of mtDNA in the drim2−/− larvae did not show the expected depletion (Fig. 7A) possibly due to their observed higher mitochondrial density (Fig. 6E). Moreover, drim2−/− larvae show a decrease of mitochondrial transcripts (Fig. 7B). These results indicate that drim2 and PNC1 are necessary for mtDNA transcription and replication in flies and humans, respectively.
Mitochondrial disorders are characterized by impaired oxygen consumption, and homozygous KO larvae and drim2-silenced cells are no exception (Fig. 8), as expected on the basis of the reduced mtDNA copy number and transcription.
Yeast Rim2 was identified in screens for suppressors of high iron toxicity in strains deleted for the two yeast mitochondrial iron transporters Mrs3 and Mrs4 or for the vacuolar iron transporter CCC1 (47, 48). Thus, the protein was proposed to play a dual role as pyrimidine nucleotide and iron transporter. However, recent data show that in wild-type yeast deletion of RIM2 alone is irrelevant for mitochondrial iron supply (49). The Drosophila genome contains mfrn, the gene for mitoferrin that is the homolog of the yeast iron carriers Mrs3 and -4. Therefore, we assume that the effects of drim2 KO detected here depend primarily on the lack of nucleotide transport into mitochondria.
Our findings strongly suggest that the D. melanogaster CG18317 (drim2) gene is essential to maintain mitochondrial function by providing deoxynucleotides for mtDNA transactions. dRIM2 is the first (deoxy)nucleotide carrier characterized in Drosophila, and our KO larvae are the first animal model of RIM2 deficiency. The data presented here may offer a key to understand the functional role of RIM2 in a multicellular animal and further support a general function in deoxynucleotide transport in mitochondria.
This work was supported by grants from the University of Padova Progetto Strategico di Ateneo, 2008 (“Models of Mitochondrial Diseases”) (to P. B., V. B., and R. C.), Fondazione CARIPLO-Scientific Research in Biomedicine 2011 (“MITGEN, Definition and Characterization of Disease Genes in Mitochondrial Disorders”) (to M. Z. and R. C.), Telethon Project GGP11011 (“MitMed, A Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders”) (to M. Z. and R. C.), Italian Telethon Grant GGP09019 (to V. B.), Italian Association for Cancer Research Grant 1091 (to V. B.), Italian Association for Cancer Research Grant 12035 (to C. T.), Fondazione Compagnia di San Paolo (to C. T.), and Telethon Program Project N. GPP10005 “Therapeutic Strategies to Combat Mitochondrial Disorders” (to M. Z. and P. B.).
This article contains supplemental Table S1.
- mt
- mitochondrial
- qRT-PCR
- quantitative PCR
- FCCP
- carbonyl cyanide p-trifluoromethoxyphenylhydrazone
- F
- forward
- R
- reverse.
REFERENCES
- 1. Magnusson J., Orth M., Lestienne P., Taanman J. W. (2003) Replication of mitochondrial DNA occurs throughout the mitochondria of cultured human cells. Exp. Cell Res. 289, 133–142 [DOI] [PubMed] [Google Scholar]
- 2. Pontarin G., Ferraro P., Bee L., Reichard P., Bianchi V. (2012) Mammalian ribonucleotide reductase subunit p53R2 is required for mitochondrial DNA replication and DNA repair in quiescent cells. Proc. Natl. Acad. Sci. U.S.A. 109, 13302–13307 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Nordlund P., Reichard P. (2006) Ribonucleotide reductases. Annu. Rev. Biochem. 75, 681–706 [DOI] [PubMed] [Google Scholar]
- 4. MacFarlane A. J., Anderson D. D., Flodby P., Perry C. A., Allen R. H., Stabler S. P., Stover P. J. (2011) Nuclear localization of de novo thymidylate biosynthesis pathway is required to prevent uracil accumulation in DNA. J. Biol. Chem. 286, 44015–44022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Anderson D. D., Quintero C. M., Stover P. J. (2011) Identification of a de novo thymidylate biosynthesis pathway in mammalian mitochondria. Proc. Natl. Acad. Sci. U.S.A. 108, 15163–15168 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Eriksson S., Munch-Petersen B., Johansson K., Eklund H. (2002) Structure and function of cellular deoxyribonucleoside kinases. Cell. Mol. Life Sci. 59, 1327–1346 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Arco A. D., Satrústegui J. (2005) New mitochondrial carriers: an overview. Cell. Mol. Life Sci. 62, 2204–2227 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Vozza A., Blanco E., Palmieri L., Palmieri F. (2004) Identification of the mitochondrial GTP/GDP transporter in Saccharomyces cerevisiae. J. Biol. Chem. 279, 20850–20857 [DOI] [PubMed] [Google Scholar]
- 9. Marobbio C. M., Di Noia M. A., Palmieri F. (2006) Identification of a mitochondrial transporter for pyrimidine nucleotides in Saccharomyces cerevisiae: bacterial expression, reconstitution, and functional characterization. Biochem. J. 393, 441–446 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Haitina T., Lindblom J., Renström T., Fredriksson R. (2006) Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics 88, 779–790 [DOI] [PubMed] [Google Scholar]
- 11. Floyd S., Favre C., Lasorsa F. M., Leahy M., Trigiante G., Stroebel P., Marx A., Loughran G., O'Callaghan K., Marobbio C. M., Slotboom D. J., Kunji E. R., Palmieri F., O'Connor R. (2007) The insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth. Mol. Biol. Cell 18, 3545–3555 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Franzolin E., Miazzi C., Frangini M., Palumbo E., Rampazzo C., Bianchi V. (2012) The pyrimidine nucleotide carrier PNC1 and mitochondrial trafficking of thymidine phosphates in cultured human cells. Exp. Cell Res. 318, 2226–2236 [DOI] [PubMed] [Google Scholar]
- 13. Van Dyck E., Jank B., Ragnini A., Schweyen R. J., Duyckaerts C., Sluse F., Foury F. (1995) Overexpression of a novel member of the mitochondrial carrier family rescues defects in both DNA and RNA metabolism in yeast mitochondria. Mol. Gen. Genet. 246, 426–436 [DOI] [PubMed] [Google Scholar]
- 14. Favre C., Zhdanov A., Leahy M., Papkovsky D., O'Connor R. (2010) Mitochondrial pyrimidine nucleotide carrier (PNC1) regulates mitochondrial biogenesis and the invasive phenotype of cancer cells. Oncogene 29, 3964–3976 [DOI] [PubMed] [Google Scholar]
- 15. Kunji E. R. (2004) The role and structure of mitochondrial carriers. FEBS Lett. 564, 239–244 [DOI] [PubMed] [Google Scholar]
- 16. Schneider I. (1972) Cell lines derived from late embryonic stages of Drosophila melanogaster. J. Embryol. Exp. Morphol. 27, 353–365 [PubMed] [Google Scholar]
- 17. Flockhart I. T., Booker M., Hu Y., McElvany B., Gilly Q., Mathey-Prevot B., Perrimon N., Mohr S. E. (2012) FlyRNAi.org–the database of the Drosophila RNAi screening center: 2012 update. Nucleic Acids Res. 40, D715–D719 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Ni J. Q., Liu L. P., Binari R., Hardy R., Shim H. S., Cavallaro A., Booker M., Pfeiffer B. D., Markstein M., Wang H., Villalta C., Laverty T. R., Perkins L. A., Perrimon N. (2009) A Drosophila resource of transgenic RNAi lines for neurogenetics. Genetics 182, 1089–1100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Pontarin G., Gallinaro L., Ferraro P., Reichard P., Bianchi V. (2003) Origins of mitochondrial thymidine triphosphate: dynamic relations to cytosolic pools. Proc. Natl. Acad. Sci. U.S.A. 100, 12159–12164 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Bianchi V., Fortunati E. (1990) Cellular effects of an anionic surfactant detected in V79 fibroblasts by different cytotoxicity tests. Toxicol. In Vitro 4, 9–16 [DOI] [PubMed] [Google Scholar]
- 21. Sherman P. A., Fyfe J. A. (1989) Enzymatic assay for deoxyribonucleoside triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem. 180, 222–226 [DOI] [PubMed] [Google Scholar]
- 22. Ferraro P., Franzolin E., Pontarin G., Reichard P., Bianchi V. (2010) Quantitation of cellular deoxynucleoside triphosphates. Nucleic Acids Res. 38, e85. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. von Stockum S., Basso E., Petronilli V., Sabatelli P., Forte M. A., Bernardi P. (2011) Properties of Ca2+ transport in mitochondria of Drosophila melanogaster. J. Biol. Chem. 286, 41163–41170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Zordan M. A., Cisotto P., Benna C., Agostino A., Rizzo G., Piccin A., Pegoraro M., Sandrelli F., Perini G., Tognon G., De Caro R., Peron S., Kronniè T. T., Megighian A., Reggiani C., Zeviani M., Costa R. (2006) Post-transcriptional silencing and functional characterization of the Drosophila melanogaster homolog of human Surf1. Genetics 172, 229–241 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Ye J., Coulouris G., Zaretskaya I., Cutcutache I., Rozen S., Madden T. L. (2012) Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13, 134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Parks A. L., Cook K. R., Belvin M., Dompe N. A., Fawcett R., Huppert K., Tan L. R., Winter C. G., Bogart K. P., Deal J. E., Deal-Herr M. E., Grant D., Marcinko M., Miyazaki W. Y., Robertson S., Shaw K. J., Tabios M., Vysotskaia V., Zhao L., Andrade R. S., Edgar K. A., Howie E., Killpack K., Milash B., Norton A., Thao D., Whittaker K., Winner M. A., Friedman L., Margolis J., Singer M. A., Kopczynski C., Curtis D., Kaufman T. C., Plowman G. D., Duyk G., Francis-Lang H. L. (2004) Systematic generation of high-resolution deletion coverage of the Drosophila melanogaster genome. Nat. Genet. 36, 288–292 [DOI] [PubMed] [Google Scholar]
- 27. Thibault S. T., Singer M. A., Miyazaki W. Y., Milash B., Dompe N. A., Singh C. M., Buchholz R., Demsky M., Fawcett R., Francis-Lang H. L., Ryner L., Cheung L. M., Chong A., Erickson C., Fisher W. W., Greer K., Hartouni S. R., Howie E., Jakkula L., Joo D., Killpack K., Laufer A., Mazzotta J., Smith R. D., Stevens L. M., Stuber C., Tan L. R., Ventura R., Woo A., Zakrajsek I., Zhao L., Chen F., Swimmer C., Kopczynski C., Duyk G., Winberg M. L., Margolis J. (2004) A complementary transposon tool kit for Drosophila melanogaster using P and piggyBac. Nat. Genet. 36, 283–287 [DOI] [PubMed] [Google Scholar]
- 28. Livak K. J., Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−ΔΔCT) method. Methods 25, 402–408 [DOI] [PubMed] [Google Scholar]
- 29. Oliveira M. T., Kaguni L. S. (2011) Reduced stimulation of recombinant DNA polymerase γ and mitochondrial DNA (mtDNA) helicase by variants of mitochondrial single-stranded DNA-binding protein (mtSSB) correlates with defects in mtDNA replication in animal cells. J. Biol. Chem. 286, 40649–40658 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Rabouille C. (1999) Quantitative aspects of immunogold labeling in embedded and nonembedded sections. Methods Mol. Biol. 117, 125–144 [DOI] [PubMed] [Google Scholar]
- 31. Andreu A. L., Martinez R., Marti R., García-Arumí E. (2009) Quantification of mitochondrial DNA copy number: pre-analytical factors. Mitochondrion 9, 242–246 [DOI] [PubMed] [Google Scholar]
- 32. Chabi B., Mousson de Camaret B., Duborjal H., Issartel J. P., Stepien G. (2003) Quantification of mitochondrial DNA deletion, depletion, and overreplication: application to diagnosis. Clin. Chem. 49, 1309–1317 [DOI] [PubMed] [Google Scholar]
- 33. Bolstad B. M., Irizarry R. A., Astrand M., Speed T. P. (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185–193 [DOI] [PubMed] [Google Scholar]
- 34. Saeed A. I., Bhagabati N. K., Braisted J. C., Liang W., Sharov V., Howe E. A., Li J., Thiagarajan M., White J. A., Quackenbush J. (2006) TM4 microarray software suite. Methods Enzymol. 411, 134–193 [DOI] [PubMed] [Google Scholar]
- 35. Huang da W., Sherman B. T., Lempicki R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44–57 [DOI] [PubMed] [Google Scholar]
- 36. Ferraro P., Pontarin G., Crocco L., Fabris S., Reichard P., Bianchi V. (2005) Mitochondrial deoxynucleotide pools in quiescent fibroblasts: a possible model for mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). J. Biol. Chem. 280, 24472–24480 [DOI] [PubMed] [Google Scholar]
- 37. Brand A. H., Perrimon N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401–415 [DOI] [PubMed] [Google Scholar]
- 38. Clay Montier L. L., Deng J. J., Bai Y. (2009) Number matters: control of mammalian mitochondrial DNA copy number. J. Genet. Genomics 36, 125–131 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Medeiros D. M. (2008) Assessing mitochondria biogenesis. Methods 46, 288–294 [DOI] [PubMed] [Google Scholar]
- 40. Ponton F., Chapuis M. P., Pernice M., Sword G. A., Simpson S. J. (2011) Evaluation of potential reference genes for reverse transcription-qPCR studies of physiological responses in Drosophila melanogaster. J. Insect Physiol. 57, 840–850 [DOI] [PubMed] [Google Scholar]
- 41. Wu M., Neilson A., Swift A. L., Moran R., Tamagnine J., Parslow D., Armistead S., Lemire K., Orrell J., Teich J., Chomicz S., Ferrick D. A. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am. J. Physiol. Cell. Physiol. 292, C125–C136 [DOI] [PubMed] [Google Scholar]
- 42. Wenz T. (2013) Regulation of mitochondrial biogenesis and PGC-1alpha under cellular stress. Mitochondrion 13, 134–142 [DOI] [PubMed] [Google Scholar]
- 43. Munch-Petersen B., Piskur J., Søndergaard L. (1998) The single deoxynucleoside kinase in Drosophila melanogaster, Dm-dNK, is multifunctional and differs from the mammalian deoxynucleoside kinases. Adv. Exp. Med. Biol. 431, 465–469 [DOI] [PubMed] [Google Scholar]
- 44. Hayward D. C., Delaney S. J., Campbell H. D., Ghysen A., Benzer S., Kasprzak A. B., Cotsell J. N., Young I. G., Miklos G. L. (1993) The sluggish-A gene of Drosophila melanogaster is expressed in the nervous system and encodes proline oxidase, a mitochondrial enzyme involved in glutamate biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 90, 2979–2983 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Ghezzi D., Arzuffi P., Zordan M., Da Re C., Lamperti C., Benna C., D'Adamo P., Diodato D., Costa R., Mariotti C., Uziel G., Smiderle C., Zeviani M. (2011) Mutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and flies. Nat. Genet. 43, 259–263 [DOI] [PubMed] [Google Scholar]
- 46. Iyengar B., Roote J., Campos A. R. (1999) The tamas gene, identified as a mutation that disrupts larval behavior in Drosophila melanogaster, codes for the mitochondrial DNA polymerase catalytic subunit (DNApol-γ125). Genetics 153, 1809–1824 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Yoon H., Zhang Y., Pain J., Lyver E. R., Lesuisse E., Pain D., Dancis A. (2011) Rim2, a pyrimidine nucleotide exchanger, is needed for iron utilization in mitochondria. Biochem. J. 440, 137–146 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Lin H., Li L., Jia X., Ward D. M., Kaplan J. (2011) Genetic and biochemical analysis of high iron toxicity in yeast: iron toxicity is due to the accumulation of cytosolic iron and occurs under both aerobic and anaerobic conditions. J. Biol. Chem. 286, 3851–3862 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Froschauer E. M., Rietzschel N., Hassler M. R., Binder M., Schweyen R. J., Lill R., Mühlenhoff U., Wiesenberger G. (2013) The mitochondrial carrier Rim2 co-imports pyrimidine nucleotides and iron. Biochem. J. 455, 57–65 [DOI] [PubMed] [Google Scholar]